No Data
No Data
No Data
No Data
No Data
Rainmed-B (02297) announces 2023 annual results. Shareholders' share loss of 116 million yuan narrowed by 91.4% year-on-year
Rainmed-B (02297) announced its results for the year ended December 31, 2023, and the group achieved acceptance during the period...
Zhitong FinanceMar 28 06:44 ET
RAINMED-B: ANNUAL RESULTS ANNOUNCEMENT FOR THE YEAR ENDED DECEMBER 31, 2023
Futu NewsMar 28 06:33 ET · Announcements
Rainmed-B (02297.HK) plans to hold a board meeting on March 28 to consider and approve annual results
Glonghui, March 8 | Runmed-B (02297.HK) announced that the company will hold a board meeting on March 28, 2024 (Thursday) to consider and approve the annual results and publication of the Company and its subsidiaries for the year ended 31 December 2023, and to consider the payment of a final dividend (if any), and to deal with other matters.
Gelonghui FinanceMar 8 05:47 ET
RAINMED-B: Date of Board Meeting
Futu NewsMar 8 05:44 ET · Announcements
Runmed-B (02297) fell 2.90% to 0.242 yuan, hitting a 52-week low
As of 15:11, Runmed-B (02297) is down 2.90% from yesterday's closing price and is now reporting a 52-week low of $0.242; the trading volume is 0.4 million shares, with a turnover of HK$0.10 million.
金吾財訊Feb 8 02:11 ET
Zheshang Securities: What are the marginal changes and investment logic of the pharmaceutical sectors in 2023Q4?
The Zhitong Finance App learned that against the backdrop of high base figures for some products in the 2022 Q4 and 2023Q1 pharmaceutical sector, the bank is more optimistic about digesting undervaluation and investment opportunities with the logic of going overseas.
Zhitong FinanceJan 9 07:46 ET
No Data
No Data